A recent study shows how a smartphone-based tool can be effectively turned into an eye-examination device. This device can take not only retinal photos but also detect early signs of diabetic retinopathy.
In a recent study, researchers from the Indian Institute of Technology (ISM) Dhanbad have developed a blood glucose sensor to monitor blood sugar using light. It can measure a wide range of values of blood glucose, between 10 to 200 mg/dl, say the researchers. The average blood sugar level in healthy adults when fasting is between 70 to 120 mg/dl.
Diabetes is a chronic, life-threatening disease affecting over 8.8% of the Indian population. These individuals often need specialised medical care and support to keep the blood glucose levels in check and ward off complications. Hypertension, a condition where the blood pressure is high, is also chronic and is known to affect about one in three adults in India. As both these conditions are chronic and life-threatening, they pose a significant burden on India’s healthcare system. But, what happens when they coexist in an individual?
A recent study, published in the Journal of Human Hypertension, highlights the plight of individuals in India, with both hypertension and diabetes.
Diabetes is a metabolic disorder where the body does not produce or effectively use the hormone insulin, resulting in elevated levels of glucose in the blood. Monitoring the amount of blood glucose can aid effective diagnosis, treatment, and access to quality healthcare management to diabetic patients. One of the ways to monitor blood glucose is through commercially available biosensors. Although such a test can be done at home at any time, there is a growing need to have pain-free alternatives. Hence, researchers are exploring glucose biosensors that do not need so much blood and are reliable, accurate, biodegradable, biocompatible and user-friendly. In a recent study, published in the journal Scientific Reports, researchers at the Indian Institutes of Technology Indore and Bombay, have developed one such sensor.
India, the world’s capital of diabetes, has an escalating diabetes epidemic. Diabetes, a non-communicable disease, affects about 8.7% Indians today, and this number is predicted to hit 70 million by 2025 and 80 million by 2030. Although the exact reasons for this rapid rise in diabetes in the country are not yet clear, experts blame it on multiple factors. In a recent study, researchers from the USA, Germany and India have investigated the status of diabetic care among Indian adults. The findings, published in the journal BMC Medicine, present a grim picture of diabetes management in different states and socio-demographic groups in India.
Researchers from Singapore, Thailand and the USA, have created an antidiabetic medicine using extracts from Withania coagulans, commonly known as the Indian Rennet or paneer dodi.
It is hard to live without a good night’s sleep. However, 22% of the people in industrialised countries do that regularly, when they work in shifts, including those during the night. Working in different shifts disrupts the body’s circadian rhythm—a natural process in our body that regulates the sleep-wake cycle.
A team of international researchers examine the cost burden of haemodialysis and found that about nine in ten households found it hard to meet the expenses, in spite of subsidies.
Researchers from Raja Ramanna Centre for Advanced Technology, Indore, Homi Bhabha National Institute, Mumbai, Indian Institute of Technology Delhi, Delhi, and Bhabha Atomic Research Centre Facility, Visakhapatnam are studying speckle variance optical coherence tomography—a new method of microscopy used to study biological materials. Their recent study checked for the possibility of using the method to microscopically monitor wound healing in real time.
Study by researchers from Institute of Public Health, Bangalore investigate how successful Primary healthcare Centres are for treating non-communicable diseases like diabetes and hypertension. They find many loopholes in the healthcare delivery system.